Open Access Open Access  Restricted Access Subscription Access

Nuclear Magnetic Resonance in Metabolism and Clinical Medicine: Part 1: NMR-Biochemical Correlation And Theranosis

Rakesh Sharma

Abstract


Magnetic Resonance Imaging and Spectroscopy with serum biomarker levels or ‘NMR-biochemical correlation’ concept has achieved as established diagnostic tool in medical practice in clinical setting. Different NMR spectroscopy methods and multimodal multiparametric MRI with MRS serve the purpose of soft tissue metabolic imaging in decision making and monitoring disease progress towards personalized medicine. Recently, new MRSI pulse sequences, localization techniques are introduced with guidelines to perform deep learning of brain, breast, prostate, liver, heart tissue biophysical and biochemical nature from digital ‘spectromics’ analysis along with other molecular imaging modalities. Different NMR methods, high resolution MRI and MRS techniques are reviewed based on MRI and MRS signals as theranostic biomarker of different soft tissue diseases with available literature on evidence based MR ‘spectromics’, clinical trials, meta-analyses.   MRI with MR spectroscopy serves as adjunct real-time, robust, fast tissue digital images. Clinical trials and guidelines on metabolic screening features evaluate the patient disease and facilitate theranosis with available medical practices in clinical setting and their limitations.


Full Text:

PDF

References


Sharma R. (1995) Studies on NMR relaxation times and NMR-biochemical Correlation in Medicine. Ph.D dissertation submitted to AIIMS/Indian Institute of Technology, New Delhi. TH-2152.pdf (iitd.ac.in) and Recent Patents in Medical Imaging. 2020; 2(2):130-149. DOI: 10.2174/1877613211202020130.

Mountford CE, Doran SJ, Lean CL, Russell P. (2004) Proton MRS can determine the pathology of human cancers with a high level of accuracy. Chem Rev. 104(8):3677 – 704.

Boada FE, Christensen JD, Huang-Hellinger FR et al.(1994) Quantittative in vivo tissue sodium concentration maps: the effects of biexponential relaxation: Magnetic Resonance in Medicine, 32: 219.

Tkac I, Gruetter R. (2005) Methodology of 1H NMR spectroscopy of the human brain at very high magnetic fields. Appl Magn Reson. 29(1):139-157.

Geppert C, Dreher W, Leibfritz D. PRESS-based proton single-voxel spectroscopy and spectroscopic imaging with very short echo times using asymmetric RF pulses. MAGMA 2003;16(3):144 – 8.

Seeger U, Klose U, Mader I, Grodd W, Nagele T. Parameterized evaluation of macromolecules and lipids in proton MR spectroscopy of brain diseases. Magn Reson Med 2003;49(1):19 – 28.

Kanowski M, Kaufmann J, Braun J, Bernarding J, Tempelmann C.Quantitation of simulated short echo time 1H human brain spe- ctra by LCModel and AMARES. Magn Reson Med 2004;51(5): 904 – 12.

Sharma R. (2002) Serial amino-neurochemicals analysis in progressive lesion analysis of multiple sclerosis by magnetic resonance imaging and proton magnetic resonance spectroscopic imaging. Magn Reson Med Sci. Nov 1;1(3):169-73.doi:10.2463/mrms.1.169. PMID: 16082140.

Grutter R, Rothman DL, Novotny E et al. (1992) Detection and assignment of glucose signal in 1H NMR difference spectra of human brain. Magnetic Resonance in Medicine. 27(1): 183.

Rothman DL, Hanstock CC, Petroff OEC et al. (1992) Localized 1H NMR spectra of glutamate in human brain. Magnetic Resonance in Medicine. 25(1): 94-106.


Refbacks

  • There are currently no refbacks.